Received Sep 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | SC |
Administered in wrong area; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of vaccine administered at inappropriate site in a 78-year-old female patient who received MMR (Priorix) for prophylaxis. On an unknown date, the patient received Priorix (subcutaneous). On an unknown date, an unknown time after receiving Priorix, the patient experienced vaccine administered at inappropriate site (Verbatim: Administered in wrong area). The outcome of the vaccine administered at inappropriate site was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 21-AUG-2025 and 22-AUG-2025 Pharmacist had called to request data regarding the validity of a Priorix dose that had been administered subcutaneously, although the pharmacist had stated it was given in the forearm.